Allarity Therapeutics, Inc. (ALLR) — Insider Trading

Key Insights

• Jeremy R. Graff, the President and Chief Development Officer of Allarity Therapeutics, Inc., has acquired 133,333 shares of the company's common stock in a direct transaction, increasing his beneficial ownership to 381,644 shares.
• The restricted stock units (RSUs) granted to Graff are subject to a vesting schedule, with one-third of the RSUs vesting on each of the first, second, and third anniversaries of the grant date, contingent on his continued relationship with the company.
• The insider transaction indicates Graff's confidence in the company's future prospects and aligns his interests with those of shareholders.